Amyloid β-peptide and oxidative cellular injury in Alzheimer's disease

Molecular Neurobiology

Volumn 12, Issue 3, 1996, Pages 211-224

  Mark, Robert J ^a   Blanc, Emmanuelle M ^a   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Astrocyte; Endothelial cell; Excitotoxicity; Free radical; Ion motive ATPase; Microglia; Nerve; Signal transduction

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; NEUROTOXIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL; BIOLOGICAL MODEL; BRAIN; BRAIN CIRCULATION; GLIA; HUMAN; LYMPHOCYTE; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; FREE RADICALS; HUMANS; LYMPHOCYTES; MODELS, NEUROLOGICAL; NEUROGLIA; NEUROTOXINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 0030155860     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02755589     Document Type: Article

References (92)

1. Yankner B. A. and Mesulam M. M. (1991) β-amyloid and the pathogenesis of Alzheimer's disease. New Engl. J. Med. 325, 1849-1857.
2. Selkoe D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci. 17, 489-517.
3. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
4. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
5. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
6. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., and Rydel R. E. (1993) β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415.
7. Levy-Lehad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., and Tanzi R. E. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
8. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. F., Bruni A. C., Montesi M. P., Sorbi S., Rainere I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Poinsky R. J., Wasco W., DaSilva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial alzheimer's disease. Nature 375, 754-760.
9. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillesple F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz E., Lieberburg I., Little S., Masllah E., McConiogue L., Montoya-Zavala M., Mucke L., Paganini M., Penniman E., Power M., Schenk D., Soubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
10. Goodman Y. and Mattson M. P. (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
11. Butterfield D. A., Hensley K., Harris M., Mattson M. P., and Carney J. (1994) β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implication to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
12. Carney J. M. and Carney A. M. (1994) Role of protein oxidation in aging and in age-associated neurodegenerative diseases. Life Sci. 55, 2097-2103.
13. Mattson M. P., Tomaselli K., and Rydel R. E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
14. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
15. 14b. Copani A., Koh J.-Y., and Cotman C. W. (1991) β-amyloid increases neuronal susceptibility to injury by glucose deprivation. Neuroreport 543, 139-147.
16. + channels. Science 264, 276-279.
17. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
18. i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
19. Cheng B., Christakos S., and Mattson M. P. (1994) Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
20. Furukawa K., Barger S. W., Blalock E. M., and Mattson M. P. (1996) Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein. Nature 379, 74-78.
21. Harris M. E., Carney J. M., Cole P. S., Hensley K., Howard B. J., Martin L., Bummer P., Wang Y., Pedigo N. W., and Butterfield D. A. (1995) β-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport 6, 1875-1879.
22. Blanc E. M., Toborek M., Mark R. J., and Mattson M. P. (1996) Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurosci., submitted.
23. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W., and Van Nostrand W. E. (1995) Amyloid Aβ-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934.
24. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
25. Dyrks T., Dyrks E., Hartmann T., Masters C., and Beyreuther K. E. (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18,210-18,217.
26. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
27. Wujek J. R., Dority M. D., Frederickson R. C. A., and Brunden K. R. (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging 17, 107-113.
28. Mattson M. P. (1995) Untangling the pathophysiochemistry of β-amyloid. Nature Struct. Biol. 2, 926-928.
29. +-ATPase. Biochim. Biophys. Acta 988, 185-220.
30. 2+ pump of the plasma membrane. J. Biol. Chem. 4, 2115-2118.
31. 2+-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes. Brain Res. 683, 36-42.
32. Kutryk M. J. B., Maddaford T. G., Ramjiawan B., and Pierce G. N. (1991) Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement. Circ. Res. 68, 18-26.
33. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
34. McClure R. J., Kanfer J. N., Panchalingam K., Klunk W. E., and Pettegrew J. W. (1994) Alzheimer's disease: membrane-associated metabolic changes. Ann. NY Acad. Sci. 747, 110-124.
35. Koh J., Yang L. L., Cotman C. W. (1990) Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
36. Miller B., Sarantis M., Traynelis F. S., and Attwell D. (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355, 722-725.
37. Weiss J. H., Pike C. J., and Cotman C. W. (1994) Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
38. Busciglio J., Yeh J., and Yankner B. A. (1993) β-amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61, 1565-1568.
39. 2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging 16, 187-198.
40. Shearman M. S., Hawtin S. R., and Tailor V. J. (1995) The intracellular component of cellular 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65, 218-227.
41. Crews F. T., Kurian P., and Freund G. (1994) Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's disease. Life Sci. 55, 1993-2002.
42. 2+ release in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
43. Sato A. and Sato Y. (1995) Cholinergic neural regulation of regional cerebral blood flow. Alzheimer Dis. Assoc. Disord. 9, 28-38.
44. Lipton S. A., Singel D. J., Stamler J. S. (1994) Nitric oxide in the central nervous system. Prog. Brain. Res. 103, 359-364.
45. Hu J. and el-Fakahany E. F. (1993) Beta-amyloid 25-35 activates nitric oxide synthase in a neuronal clone. Neuroreport 4, 760-762.
46. +)-ATPase activity from porcine cerebral cortex by NO generating drugs. Brain Res. 704, 117-120.
47. Buée L., Hof P. R., Bouras C., Delacourte A., Perl D. P., Morrison J. H., and Fillit H. M. (1994) Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 87, 469-480.
48. Bell M. and Ball M. J. (1981) Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities. Acta Neuropathol. 53, 299-318.
49. Miyakawa T., Shimoji A., Kuramoto R., and Higuchi Y. (1982) The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Virchows Arch. (Cell Pathol.) 40, 121-128.
50. Zarow C., Chui H. C., Hsu E., and Perlmutter L. S. (1989) Correlation between microangiopathy and neuronal loss in Alzheimer's disease. Soc. Neurosci. Abstr. 15, 1376.
51. Kalaria R. N. and Hedera P. (1995) Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6, 477-480.
52. Kawai M., Kalaria R. N., Cras P., Siedlak S. L., Velasco M. E., Shelton E. R., Chan H. W., Greenberg B. D., and Perry G. (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623, 142-146.
53. Perlmutter L. S. (1994) Microvasculature pathology and vascular basement membrane components in Alzheimer's disease. Mol. Neurobiol. 9, 33-40.
54. Maness L. M., Banks W. A., Podlisny M. B., Selkoe D. J., and Kastin A. J. (1994) Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 55, 1643-1650.
55. Gardella J. E., Gorgone G. A., Newman P., Frangione B., and Gorevic P. D. (1992) Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megacaryocytes. Neurosci. Lett. 138, 229-232.
56. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. J. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91, 11,993-11,997.
57. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., and Gajdusek D. C. (1989) Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
58. Wong C. W., Quaranta V., and Glenner G. G. (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. USA 82, 8729-8732.
59. Roher A. E., Lowenson J. D., Clarke S., Woods A. S., Cotter R. J., Cowing E., and Ball M. J. (1993) β-amyloid-(1-42) is a major component of cerebrovascular deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 10,836-10,840.
60. Frautschy S. A., Cole G. M., and Baird A. (1992) Phagocytosis and deposition of vascular β-amyloid in rat brains injected with Alzheimer β-amyloid. Am. J. Neuropathol. 140, 1389-1399.
61. Stewart P. A., Hayakawa K., Akers M.-A., and Vinters H. V. (1992) A morphometric study of the blood-brain barrier in Alzheimer disease. Lab. Invest. 67, 734-742.
62. Kalaria R. N. and Harik S. I. (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53, 1083-1088.
63. Thomas T., Thomas G., McLendon C., Sutton T., and Mullan M. (1996) β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171.
64. Griffin W. S. T., Sheng J. G., Gentleman S. M., Graham D. I., Mrak R. E., and Roberts G. W. (1994) Microglial interleukin-1α expression in human head injury: correlation with neuronal and neuritic β-amyloid precursor protein expression. Neurosci. Lett. 176, 133-136.
65. Araujo D. M. and Cotman C. W. (1992) Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569, 141-145.
66. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. III, and Aaroz C. (1989) Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
67. Cacabelos R., Alvarez X. A., Fernandez-Novoa L., Franco A., Mangues R., Pellicer A., and Nishimura T. (1994) Brain interleukin-1beta in Alzheimer's disease and vascular dementia. Methods Find. Exp. Clin. Pharmacol. 16, 141-151.
68. Nieto-Sampedro M. and Mora F. (1994) Active microglia, sick astroglia and Alzheimer type dementias. Neuroreport 5, 375-380.
69. Mrak R. E., Sheng J. G., and Griffin W. S. T. (1995) Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol. 26, 816-823.
70. Strijbos P. J. L. M. and Rothwell N. J. (1995) Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15, 3468-3474.
71. Giulian D., Woodward J., Young D. G., Krebs J. F., and Lachman L. (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8, 2485-2490.
72. Pike C. J., Cummings B. J., Monzavi R., and Cotman C. W. (1994) β-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517-531.
73. Haga S., Ikeda K., Sato M., and Ishii T. (1993) Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601, 88-94.
74. Walker D. G., Kim S. U., and McGeer P. L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40, 478-493.
75. Araujo D. (1992) Contrasting effects of specific lymphokines on the survival of hippocampal neurons in culture, in Treatment of Dementias (Meyer E., ed.), Plenum, New York, pp.113-122.
76. Galindo M. F., Prehn J. H. M., Bindokas V. P., and Miller R. J. (1994) Potential role of TGFβ-1 in Alzheimer's disease; regulation of APP expression and inhibition of βAP neurotoxicity. Soc. Neurosci. Abstr. 14, 1248.
77. Korotzer A. R., Pike C. J., and Cotman C. W. (1993) β-Amyloid peptides induce degeneration of cultured rat microglia. Brain Res. 624, 121-125.
78. 2+ concentration in cultured rat microglia. Eur. J. Pharmacol. 288, 125-130.
79. Piana D. and Fontana A. (1994) Macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 152, 3578-3585.
80. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., and Mattson M. P. (1996) Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors. Nature Med. 2, 788-794.
81. Eddleston M. and Mücke L. (1993) Molecular profiles of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54, 15-36.
82. Cummings B. J., Su J. H., and Cotman C. W. (1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp. Neurol. 124, 315-325.
83. Mattson M. P., Tomaselli K., and Rydel R. E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
84. Höke A., Canning D. R., Malemud C. J., and Silver J. (1994) Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp. Neurol. 130, 56-66.
85. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
86. Eckert A., Hartmann H., and Müller W. E. (1993) β-amyloid protein enhances the mitogen-induced calcium response in circulating lymphocytes. FEBS Lett. 330, 49-52.
87. Mönning U., König G., Banati R. B., Mechler H., Czech C., Gehrmann J., Schreiter-Gasser U., Masters C. L., and Beyreuther K. (1992) Alzheimer βA4-amyloid protein precursor in immunocompetent cells. J. Biol. Chem. 267, 23,950-23,956.
88. Müller W. E., Koch S., Eckert A., Hartmann H., and Scheuer K. (1995) β-amyloid peptide decreases membrane fluidity. Brain Res. 674, 133-136.
89. Eckert A., Hartmann H., Forstl H., and Müller W. E. (1994) Alterations of intracellular calcium regulation during aging and Alzheimer's disease in nonneuronal cells. Life Sci. 55, 2019-2029.
90. Goodman Y. and Mattson M. P. (1994) Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β-peptide induced oxidative injury. Brain Res. 650, 170-174.
91. Goodman Y. and Mattson M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
92. Toborek M., Barger S. W., Mattson M. P., Barve S., McClain C. J., and Hennig B. (1996) Linoleic acid and TNFa cross amplify oxidative injury and dysfunction of endothelial cells. J. Lipid Res. 37, 123-135.